Previous studies related to tumors have confirmed that CCNG1 is the target of Mir-23b through luciferase activity reporting test, and Mir-23b inhibits lung cancer cell proliferation by directly targeting CCNG1.12 This evidence concerns the gene CCNG1 and lung cancer.